Streetbeat News

Stock Prices

SSYS

Stratasys Ltd. (NASDAQ:SSYS) has adopted a new limited duration shareholder rights plan, replacing the one expiring on December 31, 2023. This Rights Plan includes enhanced shareholder protections, allowing shareholders to have a say on certain offers and potentially exempting some offers from the plan. It aims to prevent control or significant influence by an entity without fair compensation to all shareholders and encourages negotiation with the Board. The Rights Plan issues one right per share, exercisable if someone acquires 15%+ of shares without Board approval. It expires on December 19, 2024, and Meitar Law Offices and Wachtell, Lipton, Rosen & Katz are legal counsel to Stratasys.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:30 pm

CTAS

Over the past 20 years, Cintas (NASDAQ:CTAS) has produced an average annual return of 13.13%, outperforming the market by 5.63% on an annualized basis. A $100 investment in CTAS 20 years ago would be worth $1,174.97 today. Cintas currently has a market cap of $60.09 billion.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:30 pm

PCAR

Over the past 5 years, PACCAR (NASDAQ:PCAR) has produced an average annual return of 20.81%, outperforming the market by 6.87% on an annualized basis. A $1000 investment in PCAR 5 years ago would be worth $2,708.22 today. PACCAR's market capitalization currently stands at $50.69 billion.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:30 pm

CGC

CRBP

EAST

GENE

SMG

SOL

UGRO

On December 21, 2023, several marijuana stocks experienced significant price movements. Notable gainers included Blueberries Medical, iAnthus Capital Holdings, and Heritage Cannabis Holding, with increases of 15.05%, 14.44%, and 12.73% respectively. Emeren Group, Corbus Pharmaceuticals, and Scotts Miracle Gro also saw their shares rise. Conversely, MJ Holdings, Khiron Life Sciences, and Item 9 Labs were among the biggest losers, with MJ Holdings dropping 30.41%. Other notable declines were observed in Eastside Distilling, Genetic Technologies, Canopy Growth, and Cresco Labs.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:30 pm

OPTT

PGNT

Paragon Technologies (PGNT) has issued a statement to Ocean Power Technologies (OPTT) shareholders, expressing concerns about OPTT's financial performance and stock price decline under the current Board and CEO. Paragon, owning 4.9% of OPTT, criticizes the Board for misleading optimism and poor capital management, suggesting OPT could be worth over $3 per share with better cost structure and focus on Marine Advanced Robotics. Paragon urges shareholders to vote for their Blue proxy card, proposing steps to improve OPTT's performance and threatening further action if the Board does not cooperate.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:26 pm

SQFT

Presidio Property Trust, Inc. (Presidio) has regained compliance with Nasdaq's minimum bid price requirement. The company's common stock maintained a closing bid price of $1.00 or more for 10 consecutive business days, satisfying Nasdaq Listing Rule 5550(a)(2). Nasdaq has confirmed that Presidio has met the requirement and considers the matter closed.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:25 pm

NKE

Nike reported Q2 sales of $13.39 billion, falling short of the expected $13.43 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:18 pm

NKE

Nike reported Q2 earnings of $1.03 per share, surpassing the consensus estimate of $0.85, representing a 21.18% year-over-year increase. Quarterly sales reached $13.39B, exceeding estimates of $12.43B and marking a 0.55% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:15 pm

ZLAB

Zai Lab Limited (NASDAQ:ZLAB) shares fell sharply on Thursday after a recent rally. The decline followed the company's announcement last week about VYVGART, NUZYRA, and ZEJULA being added to China's 2023 National Reimbursement Drug List. Despite reaching a three-month high on Tuesday, ZLAB experienced a drop of over 10% with high trading volume of 1.21 million shares, significantly above its average of 427,978 shares.

Portfolio Pulse from Ryan Gustafson

December 21, 2023 | 9:12 pm

LMNR

Limoneira (NASDAQ:LMNR) reported Q4 earnings with an EPS of $-0.15, which was in line with estimates. Revenue increased by $1.77 million compared to the same period last year. Despite meeting EPS estimates this quarter, a previous earnings miss in Q3 2023 led to a 4.17% share price drop the following day.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:10 pm